HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mississippi PSE Prescription Switch Will Not Start An Avalanche - CHPA

This article was originally published in The Tan Sheet

Executive Summary

Mississippi lawmakers' decision to make all pseudoephedrine-containing drugs prescription-only will not prompt other states combating methamphetamine to do the same, the Consumer Healthcare Products Association predicts

You may also be interested in...

OTC Pseudoephedrine Purchases In Arkansas Require In-State Identification

An Arkansas law limits sales of pseudoephedrine-containing OTC products to consumers with in-state identification, pioneering a tactic in states' attempts to curb illegal purchases.

Missouri Looks Beyond Electronic Tracking To Rx-Only PSE In Meth Fight

Missouri's governor supports a prescription-only pseudoephedrine law, marking the latest state-level movement toward restricting access to the decongestant and precursor of methamphetamine.

CVS' Combat Meth Compliance Failings Could Fuel PSE Rx-Only Movement

A lapse in CVS' tracking of methamphetamine precursor purchases cost the drugstore chain $75 million in civil penalties and could bolster arguments that pseudoephedrine should be available by prescription only

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts